<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T19:24:13Z</responseDate>
  <request identifier="oai:figshare.com:article/34073746" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34073746</identifier>
        <datestamp>2026-10-05T17:52:37Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Internationally adapted rabies pre-exposure prophylaxis (PrEP) risk categories and recommendations. Risk categories and recommendations for PrEP, rabies virus-neutralising antibody (RVNA) titre monitoring, and booster vaccination are adapted from the 2022 United States Advisory Committee on Immunization Practices (ACIP) rabies PrEP recommendations and the 2025 CDC guidance [58]. Occupational and exposure descriptions have been simplified for international application while preserving the original risk stratification.&lt;/p&gt;</dc:title>
          <dc:creator>Stuart D. Blacksell (9740220)</dc:creator>
          <dc:creator>Khanh Kim Le (17981612)</dc:creator>
          <dc:creator>Paola De Benedictis (405039)</dc:creator>
          <dc:creator>Morgane Gourlaouen (8430900)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>potentially infectious materials</dc:subject>
          <dc:subject>personal protective equipment</dc:subject>
          <dc:subject>high fatality rate</dc:subject>
          <dc:subject>existing preventive measures</dc:subject>
          <dc:subject>clinical symptoms develop</dc:subject>
          <dc:subject>almost always fatal</dc:subject>
          <dc:subject>sample handling procedures</dc:subject>
          <dc:subject>strict biosafety measures</dc:subject>
          <dc:subject>current biosafety practices</dc:subject>
          <dc:subject>based biosafety protocols</dc:subject>
          <dc:subject>key diagnostic procedures</dc:subject>
          <dc:subject>validating inactivation methods</dc:subject>
          <dc:subject>biosafety risks associated</dc:subject>
          <dc:subject>handling rabies virus</dc:subject>
          <dc:subject>virus inactivation</dc:subject>
          <dc:subject>rabies virus</dc:subject>
          <dc:subject>biosafety constraints</dc:subject>
          <dc:subject>laboratory handling</dc:subject>
          <dc:subject>physical methods</dc:subject>
          <dc:subject>decontamination methods</dc:subject>
          <dc:subject>rabies diagnostic</dc:subject>
          <dc:subject>acquired rabies</dc:subject>
          <dc:subject>viral encephalomyelitis</dc:subject>
          <dc:subject>transmission pathways</dc:subject>
          <dc:subject>strengthening evidence</dc:subject>
          <dc:subject>research laboratories</dc:subject>
          <dc:subject>require validation</dc:subject>
          <dc:subject>related lyssaviruses</dc:subject>
          <dc:subject>particular attention</dc:subject>
          <dc:subject>limited settings</dc:subject>
          <dc:subject>knowledge gaps</dc:subject>
          <dc:subject>documented cases</dc:subject>
          <dc:subject>diagnostic standardisation</dc:subject>
          <dc:subject>comprehensive review</dc:subject>
          <dc:description>&lt;p&gt;Internationally adapted rabies pre-exposure prophylaxis (PrEP) risk categories and recommendations. Risk categories and recommendations for PrEP, rabies virus-neutralising antibody (RVNA) titre monitoring, and booster vaccination are adapted from the 2022 United States Advisory Committee on Immunization Practices (ACIP) rabies PrEP recommendations and the 2025 CDC guidance [&lt;a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0014757#pntd.0014757.ref058" target="_blank"&gt;58&lt;/a&gt;]. Occupational and exposure descriptions have been simplified for international application while preserving the original risk stratification.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-05T17:52:32Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pntd.0014757.t004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Internationally_adapted_rabies_pre-exposure_prophylaxis_PrEP_risk_categories_and_recommendations_Risk_categories_and_recommendations_for_PrEP_rabies_virus-neutralising_antibody_RVNA_titre_monitoring_and_booster_vaccination_are_adapted_fr/34073746</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
